deoxy · news / FDA MedWatch Safety Alerts

   
 
 Home · About · Bot · Category · Cloud · Link · MyNews · Search

          
FDA MedWatch Safety Alerts
Fri Nov 20 23:46:04 2009 GMT
  » FEEDSITE

  • FDA MedWatch
  • Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
  • Cardiac Science Corp. Powerheart and CardioVive Automated External Defibrillators: Initial Communica...
  • Vicks Sinex Nasal Spray - Recall
  • RockHard Weekend - product contains undeclared drug ingredient
  • Cardiovascular Systems ViperSheath Sheath Introducer - Recall
  • IDS Sports Dietary Supplements - Recall
  • Clopidogrel (marketed as Plavix) and Omeprazole (marketed as Prilosec) - Drug Interaction
  • Negative Pressure Wound Therapy (NPWT) systems - Preliminary Public Health Notification
  • Pai You Guo, Marketed as Dietary Supplement - Recall
  • Local Anesthetics, Continuously Infused (marketed as bupivacaine, chlorprocaine, lidocaine, mepivaca...
  • Genzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen
  • Synthes USA, Ti Synex II Vertebral Body Replacement - Class I Recall
  • External Biphasic Defibrillators Energy Levels: Initial Communication
  • Edwards Lifesciences CardioVations EndoClamp Aortic Catheter - Class 1 Recall
  • Hospira Brand Propofol and Liposyn Products - Recall
  • Stiff Nights - product contains undeclared drug ingredient
  • Centurion Medical Products - Premie Pack and Meconium Pack - Recall